Mike Wallenstein holds the position as Global Head Novartis MDR Implementation, External Engagement & Compliance at Novartis Pharma AG Drug Device Combination Product Compliance since April 2019. In this role, Mike oversees all activities related to the EU MDR implementation for Medical Devices & Combination Products at Novartis globally.
Prior to this position Mike was functioning as Executive Director QA to oversee all compliance activities related to Medical Devices & Combination Products at Novartis globally.
Mike is member of several US and EU Expert Committees and Interest Groups on Combination Products.
Mike joined Novartis in 2010 as Global Auditor in Group Compliance and Audit. He has over 25 years of experience in QA, R&D, and Manufacturing within the Medical Devices & Pharmaceutical Industry.
Before joining Novartis, he was Head Global Audit Systems at Gambro Renal Care (today Baxter) and European Head Quality Systems & Audits at 3M.
He studied Chemical Engineering and Plastic Technologies, in Münster, Germany.